Australia markets closed

Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
34.51+0.29 (+0.85%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 82.61B
Enterprise value 84.67B
Trailing P/E 11.04
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.56
Price/book (mrq)2.53
Enterprise value/revenue 1.59
Enterprise value/EBITDA 9.66

Trading information

Stock price history

Beta (5Y monthly) 0.81
52-week change 3-28.47%
S&P500 52-week change 326.49%
52-week high 370.27
52-week low 333.51
50-day moving average 343.31
200-day moving average 351.11

Share statistics

Avg vol (3-month) 320.29M
Avg vol (10-day) 320.2M
Shares outstanding 52.39B
Implied shares outstanding 62.44B
Float 8981.12M
% held by insiders 159.12%
% held by institutions 116.50%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.5
Forward annual dividend yield 41.45%
Trailing annual dividend rate 30.80
Trailing annual dividend yield 32.34%
5-year average dividend yield 40.66
Payout ratio 416.00%
Dividend date 3N/A
Ex-dividend date 416 June 2023
Last split factor 21.54:1
Last split date 316 June 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 14.10%
Operating margin (ttm)15.25%

Management effectiveness

Return on assets (ttm)10.97%
Return on equity (ttm)25.44%

Income statement

Revenue (ttm)53.14B
Revenue per share (ttm)22.16
Quarterly revenue growth (yoy)2.00%
Gross profit (ttm)N/A
EBITDA 8.8B
Net income avi to common (ttm)7.5B
Diluted EPS (ttm)3.12
Quarterly earnings growth (yoy)-28.30%

Balance sheet

Total cash (mrq)2.97B
Total cash per share (mrq)1.24
Total debt (mrq)5.04B
Total debt/equity (mrq)15.42%
Current ratio (mrq)2.26
Book value per share (mrq)13.61

Cash flow statement

Operating cash flow (ttm)5.76B
Levered free cash flow (ttm)-1.64B